Related Experiment Video
Updated: Oct 17, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms
Lorenza Pastorino1,2, Federica Grillo3,4, Manuela Albertelli2,5
1Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.
Abstract:
Genomic studies have identified some of the most relevant genetic players in Neuroendocrine Neoplasm (NEN) tumorigenesis. However, we are still far from being able to draw a model that encompasses their heterogeneity, elucidates the different biological effects consequent to the identified molecular events, or incorporates extensive knowledge of molecular biomarkers and therapeutic targets. Here, we reviewed recent insights in NEN tumorigenesis from selected basic research studies on animal models, highlighting novel players in the intergenic cooperation and peculiar mechanisms including splicing dysregulation, chromatin stability, or cell dedifferentiation. Furthermore, models of tumorigenesis based on composite interactions other than a linear progression of events are proposed, exemplified by the involvement in NEN tumorigenesis of genes regulating complex functions, such as MEN1 or DAXX. Although limited by interspecies differences, animal models have proved helpful for the more in-depth study of every facet of tumorigenesis, showing that the identification of driver mutations is only one of the many necessary steps and that other mechanisms are worth investigating.
Insights
Genomic studies reveal key genetic drivers in Neuroendocrine Neoplasm (NEN) tumorigenesis. Animal models highlight complex mechanisms beyond simple mutations, emphasizing intergenic cooperation and epigenetic factors for a comprehensive understanding.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Genomic studies have identified critical genetic factors in Neuroendocrine Neoplasm (NEN) development.
- Current models lack a comprehensive understanding of NEN heterogeneity, biological effects, biomarkers, and therapeutic targets.
Purpose of the Study:
- To review recent insights into NEN tumorigenesis using animal models.
- To highlight novel genetic players, cooperative mechanisms, and regulatory pathways involved in NEN development.
Main Methods:
- Review of selected basic research studies on animal models of NEN.
- Analysis of genetic and molecular mechanisms including splicing, chromatin stability, and cell dedifferentiation.
Main Results:
- Identified novel players in intergenic cooperation within NEN tumorigenesis.
- Highlighted peculiar mechanisms such as splicing dysregulation, chromatin instability, and cell dedifferentiation.
- Proposed composite models of tumorigenesis involving genes like MEN1 and DAXX, moving beyond linear progression.
Conclusions:
- Animal models provide valuable insights into NEN tumorigenesis, despite interspecies differences.
- Understanding NEN requires investigating mechanisms beyond driver mutations, including epigenetic and regulatory factors.
- Further research into complex interactions and novel pathways is crucial for NEN biomarker and therapeutic target discovery.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

